MLN-608

N/A

Report date: 2023/05/22 10:18:17

NME

Base Information

Drug NameMLN-608

Drug Alias NameMLN608

ClassificationSmall molecules

Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsStem cell growth factor receptor inhibitorsTyrosine-protein kinase receptor FLT3 inhibitors

TargetsStem cell growth factor receptorTyrosine-protein kinase receptor FLT3Platelet-derived growth factor receptor

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMillennium Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMillennium Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A